Free Trial

The Pennant Group (NASDAQ:PNTG) Hits New 12-Month High at $22.00

→ The Worst is Yet to Come… (From Porter & Company) (Ad)
The Pennant Group logo with Medical background

The Pennant Group, Inc. (NASDAQ:PNTG - Get Free Report)'s stock price hit a new 52-week high during trading on Tuesday . The stock traded as high as $22.00 and last traded at $21.81, with a volume of 12281 shares changing hands. The stock had previously closed at $21.57.

Analysts Set New Price Targets

Several brokerages recently commented on PNTG. Oppenheimer upped their price target on shares of The Pennant Group from $18.00 to $22.00 and gave the company an "outperform" rating in a report on Friday, March 1st. Truist Financial boosted their price objective on shares of The Pennant Group from $16.00 to $21.00 and gave the company a "hold" rating in a research report on Friday, March 1st. Finally, Stephens reissued an "overweight" rating and issued a $23.00 price objective on shares of The Pennant Group in a research report on Tuesday.

View Our Latest Stock Analysis on PNTG

The Pennant Group Price Performance

The firm's 50-day moving average price is $19.87 and its two-hundred day moving average price is $16.18. The stock has a market cap of $627.51 million, a PE ratio of 47.52, a PEG ratio of 2.26 and a beta of 2.01. The company has a current ratio of 1.12, a quick ratio of 1.12 and a debt-to-equity ratio of 0.44.

The Pennant Group (NASDAQ:PNTG - Get Free Report) last announced its quarterly earnings results on Wednesday, February 28th. The company reported $0.18 earnings per share for the quarter, missing the consensus estimate of $0.19 by ($0.01). The Pennant Group had a return on equity of 12.78% and a net margin of 2.46%. The business had revenue of $145.95 million during the quarter, compared to analysts' expectations of $136.79 million. During the same period in the previous year, the company posted $0.15 EPS. On average, equities analysts expect that The Pennant Group, Inc. will post 0.73 earnings per share for the current fiscal year.


Institutional Investors Weigh In On The Pennant Group

A number of hedge funds and other institutional investors have recently bought and sold shares of the company. 8 Knots Management LLC purchased a new stake in The Pennant Group during the fourth quarter valued at approximately $25,578,000. Vanguard Group Inc. increased its stake in The Pennant Group by 0.8% during the 3rd quarter. Vanguard Group Inc. now owns 1,693,196 shares of the company's stock valued at $18,845,000 after purchasing an additional 14,138 shares in the last quarter. Wasatch Advisors LP increased its stake in The Pennant Group by 3.3% during the 4th quarter. Wasatch Advisors LP now owns 1,465,754 shares of the company's stock valued at $20,403,000 after purchasing an additional 46,484 shares in the last quarter. Paradigm Capital Management Inc. NY increased its stake in The Pennant Group by 79.1% during the 3rd quarter. Paradigm Capital Management Inc. NY now owns 1,196,500 shares of the company's stock valued at $13,317,000 after purchasing an additional 528,612 shares in the last quarter. Finally, Crewe Advisors LLC increased its stake in The Pennant Group by 0.7% during the 4th quarter. Crewe Advisors LLC now owns 1,108,104 shares of the company's stock valued at $15,425,000 after purchasing an additional 7,797 shares in the last quarter. Hedge funds and other institutional investors own 85.88% of the company's stock.

About The Pennant Group

(Get Free Report)

The Pennant Group, Inc provides healthcare services in the United States. It operates in two segments, Home Health and Hospice Services, and Senior Living Services. The company offers home health services, including clinical services, such as nursing, speech, occupational and physical therapy, medical social work, and home health aide services; and hospice services comprising clinical care, education, and counseling services for the physical, spiritual, and psychosocial needs of terminally ill patients and their families.

Recommended Stories

→ The Worst is Yet to Come… (From Porter & Company) (Ad)

Should you invest $1,000 in The Pennant Group right now?

Before you consider The Pennant Group, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and The Pennant Group wasn't on the list.

While The Pennant Group currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

12 Stocks Corporate Insiders are Abandoning Cover

If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

4 Downgraded Stocks Still Worth a Look

4 Downgraded Stocks Still Worth a Look

Despite recent analyst downgrades, these stocks might offer golden opportunities to buy on a dip.

Recent Videos

Profit Like Congress: The Stocks They’re Betting On
Cathie Wood’s AMD Buy: Smart Move or Risky Business
4 of the Best Stocks for Share Buybacks

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines